PHASE 2 STUDY OF PEMBROLIZUMAB PLUS TTFIELDS PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)

被引：0
|
作者：
Tran, David [1 ]
Ghinaseddin, Ashley [2 ]
Chen, Dongjiang [2 ]
Rahman, Maryam [2 ]
机构：
[1] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA
[2] Univ Florida, Gainesville, FL USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTIM-16
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Final analysis of 2-THE-TOP: A phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma
    Tran, David D.
    Ghiaseddin, Ashley Parham
    Chen, Dongjiang D.
    Le, Son B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] UPDATES FOR A PHASE 2 OPEN-LABELED STUDY OF PEMBROLIZUMAB PLUS TTFIELDS PLUS MAINTENANCE TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)
    Ghiaseddin, Ashley
    Warren, Sonisha
    Allen, Annie
    Sampson, Deborah
    Chen, Dongjiang
    Sherman, Alexandra
    Greene, Valerie
    Rahman, Maryam
    Tran, David
    NEURO-ONCOLOGY, 2020, 22 : 33 - 33
  • [3] FINAL RESULTS OF 2-THE-TOP: A PILOT PHASE 2 STUDY OF TTFIELDS (OPTUNE) PLUS PEMBROLIZUMAB PLUS MAINTENANCE TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
    Tran, David
    Ghiaseddin, Ashley
    Chen, Dongjiang
    Le, Son
    Rahman, Maryam
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
  • [4] FINAL EFFICACY AND CORRELATIVE ANALYSES OF 2-THE-TOP: A PILOT STUDY OF TTFIELDS (OPTUNE) PLUS PEMBROLIZUMAB PLUS MAINTENANCE TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
    Tran, David
    Chen, Dongjiang
    Le, Son
    Ghiaseddin, Ashley
    NEURO-ONCOLOGY, 2023, 25
  • [5] PHASE 2 OPEN-LABELED STUDY OF ADJUVANT TEMOZOLOMIDE PLUS TUMOR TREATING FIELDS PLUS PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)
    Tran, David
    Warren, Sonisha
    Allen, Anne
    Sampson, Deborah
    Chen, Dongjiang
    Thomas, Nagheme
    Greene, Valerie
    Rahman, Maryam
    Ghiaseddin, Ashley
    NEURO-ONCOLOGY, 2019, 21 : 10 - 10
  • [6] PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) PLUS RADIATION THERAPY (RT) PLUS TEMOZOLAMIDE (TMZ) COMPARED TO RT PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Blumenthal, Deborah
    Ram, Zvi
    NEURO-ONCOLOGY, 2020, 22 : 196 - 196
  • [7] Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Ahluwalia, Manmeet S.
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Figel, Sheila A.
    Mechtler, Laszlo L.
    Peereboom, David M.
    Hutson, Alan D.
    Withers, Henry G.
    Liu, Song
    Belal, Ahmed N.
    Qiu, Jingxin
    Mogensen, Kathleen M.
    Dharma, Sanam S.
    Dhawan, Andrew
    Birkemeier, Meaghan T.
    Casucci, Danielle M.
    Ciesielski, Michael J.
    Fenstermaker, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1453 - +
  • [8] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Ciesielski, Michael J.
    Reardon, David A.
    Abad, Ajay
    Curry, William
    Wong, Eric
    Peereboom, David
    Figel, Sheila
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry
    Liu, Song
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Khosla, Atulya
    Casucci, Danielle
    Mechtler, Laszlo
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [9] A PHASE I STUDY OF AT-101 PLUS RADIOTHERAPY AND TEMOZOLOMIDE AND AT-101 PLUS ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Fiveash, John
    Nabors, Louis B.
    Mikkelsen, Tom
    Peereboom, David M.
    Lesser, Glenn J.
    Chowdhary, Sajeel A.
    Grossman, Stuart
    Ye, Xiaubu
    Leopold, Lance
    Rosenfeld, Myrna
    NEURO-ONCOLOGY, 2009, 11 (05) : 666 - 666
  • [10] Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
    Schiff, David
    Huse, Jason
    Wen, Patrick
    NEURO-ONCOLOGY, 2014, 16 (06) : 769 - 769
12345